An insertion–deletion polymorphism in interleukin-1α gene associated with susceptibility to preeclampsia

References

• Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009;33:130–7
   PubMed Web of Science ®Google Scholar
• Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999;180:499–506
   PubMed Web of Science ®Google Scholar
• Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension 2005;46:1243–9
   PubMed Web of Science ®Google Scholar
• Friedman SA. Preeclampsia: a review of the role of prostaglandins. Obstet Gynecol 1988;71:122–37
   PubMed Web of Science ®Google Scholar
• Tsatsaris V, Fournier T, Winer N. Pathophysiology of preeclampsia. J Gynecol Obstet Biol Reprod (Paris) 2008;37:16–23
   PubMedGoogle Scholar
• Challis JR, Lockwood CJ, Myatt L, et al. Inflammation and pregnancy. Reprod Sci 2009;16:206–15
   PubMed Web of Science ®Google Scholar
• Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol 1998;179:1359–75
   PubMed Web of Science ®Google Scholar
• Tsatsaris V, Fournier T, Winer N. Pathophysiology of preeclampsia. Ann Fr Anesth Reanim 2010;29:e13–18
   PubMedGoogle Scholar
• Turner DM, Williams DM, Sankaran D, et al. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997;24:1–8
   PubMedGoogle Scholar
• Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996;87:2095–147
   PubMed Web of Science ®Google Scholar
• Hirsiger S, Simmen HP, Werner CM, et al. Danger signals activating the immune response after trauma. Mediators Inflamm 2012;2012:315941. doi: 10.1155/2012/315941
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991;77:1627–52
   PubMed Web of Science ®Google Scholar
• Petrasek J, Bala S, Csak T, et al. IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J Clin Invest 2012;122:3476–89
   PubMed Web of Science ®Google Scholar
• Yazdi AS, Drexler SK. Regulation of interleukin 1alpha secretion by inflammasomes. Ann Rheum Dis 2013;72:ii96–9
   PubMed Web of Science ®Google Scholar
• Gao Y, He Y, Ding J, et al. An insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-1alpha 3′ untranslated region confers risk for hepatocellular carcinoma. Carcinogenesis 2009;30:2064–9
   PubMed Web of Science ®Google Scholar
• Hata Y, Nakaoka H, Yoshihara K, et al. A nonsynonymous variant of IL1A is associated with endometriosis in Japanese population. J Hum Genet 2013;58:517–20
   PubMed Web of Science ®Google Scholar
• Yang ZH, Dai Q, Zhong L, et al. Association of IL-1 polymorphisms and IL-1 serum levels with susceptibility to nasopharyngeal carcinoma. Mol Carcinog 2011;50:208–14
   PubMed Web of Science ®Google Scholar
• Zeng XF, Li J, Li SB. A functional polymorphism in IL-1A gene is associated with a reduced risk of gastric cancer. Tumour Biol 2013;35:265–8
   Google Scholar
• Sibai BM, Stella CL. Diagnosis and management of atypical preeclampsia-eclampsia. Am J Obstet Gynecol 2009;200:481 e1–7
   Web of Science ®Google Scholar
• Al-Jameil N, Aziz Khan F, Fareed Khan M, Tabassum H. A brief overview of preeclampsia. J Clin Med Res 2014;6:1–7
   PubMedGoogle Scholar
• Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005;308:1592–4
   PubMed Web of Science ®Google Scholar
• Arias F, Rodriquez L, Rayne SC, Kraus FT. Maternal placental vasculopathy and infection: two distinct subgroups among patients with preterm labor and preterm ruptured membranes. Am J Obstet Gynecol 1993;168:585–91
   PubMed Web of Science ®Google Scholar
• Di Renzo GC. The great obstetrical syndromes. J Matern Fetal Neonatal Med 2009;22:633–5
   PubMed Web of Science ®Google Scholar
• Palei AC, Spradley FT, Warrington JP, et al. Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology. Acta Physiol (Oxf) 2013;208:224–33
   PubMed Web of Science ®Google Scholar
• Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001;357:53–6
   PubMed Web of Science ®Google Scholar
• Apte RN, Voronov E. Is interleukin-1 a good or bad ‘guy' in tumor immunobiology and immunotherapy? Immunol Rev 2008;222:222–41
   PubMed Web of Science ®Google Scholar
• Ramadori G, Sipe JD, Dinarello CA, et al. Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin 1 (IL-1) and purified human IL-1. J Exp Med 1985;162:930–42
   PubMed Web of Science ®Google Scholar
• Neta R, Oppenheim JJ. Why should internists be interested in interleukin-1? Ann Intern Med 1988;109:1–3
   PubMed Web of Science ®Google Scholar
• Kimya Y, Akdis C, Cengiz C, et al. Plasma interleukin-1alpha, interleukin-1beta and interleukin-1 receptor antagonist levels in pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 1997;73:17–21
   PubMed Web of Science ®Google Scholar
• Chin LJ, Ratner E, Leng S, et al. A SNP in a let-7 microRNA complementary site in the KRAS 3′ untranslated region increases non-small cell lung cancer risk. Cancer Res 2008;68:8535–40
   PubMed Web of Science ®Google Scholar
• Landi D, Gemignani F, Naccarati A, et al. Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer. Carcinogenesis 2008;29:579–84
   PubMed Web of Science ®Google Scholar